Attorney General
Here's a look at documents from state attorneys general
Featured Stories
Okla. A.G. Drummond Announces Lawsuit Against Uber
OKLAHOMA CITY, Oklahoma, Dec. 19 -- Oklahoma Attorney General Gentner Drummond issued the following news release on Dec. 18, 2025:
* * *
Drummond announces lawsuit against Uber
Attorney General Gentner Drummond has filed a lawsuit against Uber Technologies LLC and Uber USA LLC, alleging they used a variety of deceptive and unfair practices in selling Uber One subscription services.
Drummond and a coalition of 21 other state attorneys general joined the lawsuit Monday, which was filed earlier by the Federal Trade Commission.
Drummond said Uber is accused of improperly using negative option
... Show Full Article
OKLAHOMA CITY, Oklahoma, Dec. 19 -- Oklahoma Attorney General Gentner Drummond issued the following news release on Dec. 18, 2025:
* * *
Drummond announces lawsuit against Uber
Attorney General Gentner Drummond has filed a lawsuit against Uber Technologies LLC and Uber USA LLC, alleging they used a variety of deceptive and unfair practices in selling Uber One subscription services.
Drummond and a coalition of 21 other state attorneys general joined the lawsuit Monday, which was filed earlier by the Federal Trade Commission.
Drummond said Uber is accused of improperly using negative optionmarketing tactics when it offered free trial subscriptions - a practice that automatically charges consumers if they do not cancel a free trial. Uber allegedly misled consumers about the amounts they could save when subscribing to Uber One and made it extraordinarily difficult for consumers to cancel once enrolled. Uber is also accused of charging consumers before their billing date, including users whose free trial had not yet ended.
"Oklahoma law prohibits deceptive trade practices and I will always fight to hold accountable any company who breaks the law," Drummond said. "Unless Uber is stopped in court, they are likely to continue cheating and harming hardworking Oklahomans."
The lawsuit seeks restitution, as well as penalties, costs and an injunction against Uber for alleged violations of Oklahoma's Consumer Protection Act and the U.S. Restore Online Shoppers' Confidence Act.
The lawsuit is pending in the U.S. District Court for the Northern District of California with a trial currently scheduled for February 2027.
In addition to Oklahoma, the state coalition includes Maryland, Alabama, Arizona, Connecticut, the District of Columbia, Illinois, Michigan, Minnesota, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Virginia, West Virginia, and Wisconsin, as well as the District Attorney for Alameda County in California.
Read the Complaint (https://oklahoma.gov/content/dam/ok/en/oag/news-documents/2025/december/2025.12.15%20FTC%20et%20al%20v.%20Uber%20et%20al%20First%20Amended%20Complaint%20Redacted%20Public.pdf)
* * *
Original text here: https://oklahoma.gov/oag/news/newsroom/2025/december/drummond-announces-lawsuit-against-uber.html
Del. A.G. Jennings Secures Court Order Protecting SNAP Benefits
DOVER, Delaware, Dec. 19 -- Delaware Attorney General Kathy Jennings issued the following statement on Dec. 18, 2025:
* * *
Attorney General Jennings secures court order protecting SNAP benefits
Delaware Attorney General Kathy Jennings released the following statement after a federal judge blocked the Trump administration's efforts to penalize states with millions of dollars in fines related to their Supplemental Nutrition Assistance Program (SNAP) operations:
"It is shameful that, yet again, we've had to force the Trump Administration to simply follow the law and let vulnerable Delawareans
... Show Full Article
DOVER, Delaware, Dec. 19 -- Delaware Attorney General Kathy Jennings issued the following statement on Dec. 18, 2025:
* * *
Attorney General Jennings secures court order protecting SNAP benefits
Delaware Attorney General Kathy Jennings released the following statement after a federal judge blocked the Trump administration's efforts to penalize states with millions of dollars in fines related to their Supplemental Nutrition Assistance Program (SNAP) operations:
"It is shameful that, yet again, we've had to force the Trump Administration to simply follow the law and let vulnerable Delawareansfeed their families," said Attorney General Kathy Jennings. "We have had to sue this Administration more than 40 times this year alone, and we will continue to do so every time they threaten my constituents."
On November 26, 2025, Attorney General Jennings joined a coalition of 21 attorneys general in suing the Trump administration after it attempted to cut off SNAP benefits for tens of thousands of lawful permanent residents. On December 10, the administration reversed itself and issued new guidance, confirming that lawful permanent residents - including former refugees and asylees - remain eligible for SNAP benefits. Despite that reversal, the administration continued to threaten states with millions of dollars in fines, claiming that states had missed a required "grace period" for implementing the new guidance, even though the final guidance was not issued until December 10.
On December 15, 2025, the U.S. District Court for the District of Oregon issued an order temporarily blocking those penalties. The court's decision prohibits the federal government's efforts to impose severe financial penalties on states and protects the continued operation of SNAP programs while the case proceeds.
* * *
Original text here: https://news.delaware.gov/2025/12/18/attorney-general-jennings-secures-court-order-protecting-snap-benefits/
N.H. A.G. Formella Pushes Meta to Take Action on Misleading AI Weight Loss Ads
CONCORD, New Hampshire, Dec. 18 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
Attorney General Formella Pushes Meta to Take Action on Misleading AI Weight Loss Ads
Attorney General John M. Formella and a bipartisan coalition of attorneys general are calling on Meta to better enforce its own policies about pharmaceutical and wellness ads on Instagram and Facebook and take additional measures to prevent AI-generated weight loss content in ads. These ads are likely to see an uptick during the holiday season and the new year, when conversations around weight
... Show Full Article
CONCORD, New Hampshire, Dec. 18 -- New Hampshire Attorney General John Formella issued the following news release:
* * *
Attorney General Formella Pushes Meta to Take Action on Misleading AI Weight Loss Ads
Attorney General John M. Formella and a bipartisan coalition of attorneys general are calling on Meta to better enforce its own policies about pharmaceutical and wellness ads on Instagram and Facebook and take additional measures to prevent AI-generated weight loss content in ads. These ads are likely to see an uptick during the holiday season and the new year, when conversations around weightloss and appearance tend to increase.
"Consumers deserve honest information, especially when it comes to their health," said Attorney General Formella. "Meta already has deceptive pharmaceutical and wellness advertising prevention policies in place, but those rules are meaningless if they are not enforced. We are urging Meta to take commonsense steps to stop misleading and AI-generated weight loss ads that prey on people's insecurities, misrepresent medical risks, and undermine trust in online marketplaces."
GLP-1 weight loss drugs have exploded in popularity over the last few years, as have ads selling the drugs directly to consumers. Dozens of companies are using Meta's advertising tools to run thousands of ads promoting GLP-1 drugs, most of which are non-FDA approved or compounded.
Meta has existing policies on pharmaceutical and health and wellness ads - but it is not sufficiently enforcing them. Advertisers are supposed to share information about the medical effectiveness and affordability of drugs, only target adults, and not run ads that push a "perfect" body type or foster unhealthy body images.
But the ads on Meta's platforms capitalize on people's dissatisfaction with their bodies and promote weight loss as a tool for self-confidence, desirability, and social mobility - not health. Many ads use body close-ups and side-by-side comparisons and promote weight loss for milestones like the holiday season, weddings, birthdays, and vacations. These ads claim that the drugs will help with rapid weight loss without disclosing the risks and side effects of these medications.
Often, these ads use unlabeled AI-generated content including fake before and after images and nonexistent spokespeople. One ad shows an AI-generated model losing 208 pounds in three weeks. Others use fake AI-created law enforcement officers, nurses, and pharmacists to support their weight loss claims.
In addition to enforcing its existing policies, the attorneys general are asking Meta to:
* Restrict prescription drug ads in the United States to only those that are FDA-approved.
* Require content promoting weight loss products to clearly disclose the risks and potential side effects.
* Prohibit weight loss drug ads that use AI- generated content.
* Label AI-generated content more clearly and develop better tools to detect and remove content that isn't properly labeled.
* Redirect people to safety and educational resources for weight loss products when they search for those products.
The New Hampshire Department of Justice Consumer Protection and Antitrust Bureau investigates unfair, deceptive or unreasonable practices involving New Hampshire consumers. To file a complaint with the New Hampshire Department of Justice, call the Consumer Protection Hotline at 1-888-468-4454 or file a complaint online at https://www.doj.nh.gov/consumer/complaints.
Letter: ltr-to-meta-re-glp-w-ag-office-seals.pdf (https://www.doj.nh.gov/sites/g/files/ehbemt721/files/inline-documents/sonh/ltr-to-meta-re-glp-w-ag-office-seals.pdf)
* * *
SENT VIA EMAIL AND FIRST-CLASS MAIL
To: Meta Platforms, Inc., c/o Ms. Jennifer Newstead, Chief Legal Officer, 1 Meta Way, Menlo Park, California 94025
Re: Weight Loss Advertisements
Dear Ms. Newstead:
We write regarding the surge of misleading marketing for weight loss products on Meta's platforms. This advertising--much of which is AI-generated--seizes on consumers' insecurities and health concerns, often to boost unapproved and potentially dangerous drugs. Users on Facebook, Instagram, and other Meta platforms are being inundated with promotions that feature misleading claims, obscure risks and side effects, and deceive viewers with AI-generated content. A significant volume of these advertisements violate your own policies on pharmaceuticals, weight loss products, misleading health practices, and manipulated content. We urge Meta to enforce those policies more vigorously and to quickly take further steps to protect consumers from predatory AI-generated weight loss advertisements.
GLP-1s have exploded in popularity in the last several years. The Food and Drug Administration has approved a number of these drugs as treatments for type 2 diabetes, obesity and related conditions like cardiovascular disease and chronic kidney disease, including Ozempic, Wegovy, Mounjaro, and Zepbound. GLP-1s can have life-changing benefits for patients managing these conditions when used as indicated and with proper medical supervision. But direct to consumer advertising of GLP-1 drugs has skyrocketed1 and your platforms are no exception:
Dozens of companies are using your advertising tools to run thousands of ads promoting GLP-1s./2 Relatively few are offering FDA-approved medications; most are selling unapproved compounded products.
Meta is supposed to place guardrails on pharmaceutical advertisements through company policies. Meta's Prescription Drugs Advertising Policy prohibits the promotion of prescription drugs without Meta's authorization./3 When authorized, advertisers are supposed to limit promotions to those that "share information around medical efficacy, accessibility and affordability of different types of treatments," avoid targeting minors, and comply with Meta's other policies./4 Meta's Health and Wellness Advertising Policy, meanwhile, prohibits ads for weight loss products "that imply or attempt to generate negative self-perception or declare there is a perfect body type or appearance one should aspire to."/5 It also bars promotions of weight loss products using side-by-side comparisons, body close ups, "[d]istateful messaging that could make people feel negatively about the way they look," and content fostering "negative or unhealthy body images."/6
Yet Instagram and Facebook are replete with ads that conflict with these policies. As a recent study found, GLP-1 ads on your platforms commonly "appeal to consumers' emotional motivations for weight loss and self-improvement," exploit societal beauty ideals that may contribute to body dissatisfaction, and "often position weight loss not solely as a health goal but as a means to achieve improved self-confidence, desirability, and social mobility."/7
This is evident in many ads that, despite your policies, employ side-by-side comparisons and body close-ups. Other ads take advantage of negative body image to promote cosmetic weight loss, even for young women who may not meet the medical criteria for GLP-1 treatment. This often takes the form of promoting weight loss for milestones like weddings, birthdays, holidays, or vacations. For example, a Willow ad proclaims, "Hey girly. It's time to drop 2 pant sizes before summer."/8 Feels and Medvi ads encourage viewers to "get snatched before Christmas with tirzepatide."/9 And a Direct Meds ad encourages viewers to "lose 43 pounds before New Years."/10
Many ads on your platforms also claim drastic weight loss without adequately disclosing potential risks and side effects. These target the large number of consumers "eager for rapid solutions,"/11 regardless of the risk to their health. In doing so, they run afoul of Meta's prohibition on content that "[p]romotes false or misleading health claims or guarantees in a weight loss context by employing click-bait tactics, such as the use of sensational language that make exaggerated or extreme claims."/12 To give a few examples: a Mochi ad touts an impressive average weight loss of 36-pounds./13 Another features a spokeswoman claiming her clothes are looser after just two weeks while boasting that she had not eaten all day because she was not hungry.14 One Medvi ad even guarantees "no side effects . . . just real results."/15 These kinds of ads play up the benefits and minimize the potential downsides, undermining consumers' ability to make fully informed choices about their health care.
AI-generated content is deepening these risks. Advertisers are misleadingly using AIgenerated fictitious spokespersons and falsified before-and-after sequences to boost GLP-1s./16 For instance, one TrimRx ad includes an AI-generated model dramatically losing 208 pounds as an upbeat voiceover boasts "Three weeks you guys, oh my gosh three weeks! This stuff works for real. You need to get on Trim Rx."/17 Other ads feature testimonials from trusted sources--such as law enforcement, nurses, pharmacists, and military personnel--to bolster their claims. The problem: none of these people are real./18
The risk is only increasing as AI video generation is rapidly becoming more sophisticated, and therefore harder to detect./19 The "before" clip in one Direct Meds ad touting the loss of 58 pounds is difficult to identify as AI generated without repeatedly playing the video and scrutinizing its fine details--which consumers are unlikely to do while casually scrolling social media./20 Meta has acknowledged the importance of informing users that content has been AI-generated and provides an AI-disclosure tool for advertisers,/21 yet many of these ads include no such disclosures.
Many ads on your platforms risk misleading consumers regarding compounded GLP-1s. Federal law permitted compounding pharmacies to produce GLP-1 medications in bulk outside of the ordinary drug approval process during a shortage of FDA-approved medications./22 However, that shortage ended months ago.23 Now, compounding is only permitted in important, but narrow, circumstances./24 Regulators, law enforcement, and health organizations alike have cautioned against widespread use of compounded GLP-1s./25 These drugs are not FDA reviewed for safety, efficacy, and quality./26 They can have significantly different formulations from approved medications--including active ingredients imported from uninspected foreign facilities, formulation differences, and impurities./27 These compounded drugs, many in unproven formulations such as liquid solutions, sublingual drops, pills, formulas with added vitamins, and so-called "microdoses," essentially amount to "a mass experiment on unsuspecting patients."/28 Dozens of ads blur these distinctions by suggesting that compounded medications are FDA approved, identical to approved drugs, or even safer and more effective than those drugs. As the FDA recently stated in warnings to numerous compounders and telehealth companies, these kinds of claims are false and misleading in violation of the Federal Food, Drug, and Cosmetic Act./29
We appreciate that Meta has adopted certain policies regarding pharmaceutical and weight loss ads. But those policies are being circumvented and are inadequate to address the scope of these issues. We note that the problem is not confined to paid advertising, either: numerous influencers and affiliate marketers are boosting GLP-1 medications without the transparency required by federal regulations and your policies.30 Troublingly, emerging evidence indicates that social media marketing is shaping consumers' views about and interest in GLP-1s./31 We urge Meta--at a minimum--to enforce its existing policies more vigorously. We also ask Meta to take additional steps to protect the public, including:
* Restricting the advertisement of prescription pharmaceuticals in the United States to those that are FDA approved;
* Requiring content promoting weight loss products to clearly and conspicuously disclose the risks and potential side effects;
* Prohibiting the promotion of weight loss drugs using AI-generated content such as spokespeople, testimonials, and before and after images;
* Employing more prominent AI-generated content labeling and developing better tools to detect and remove content not properly labeled;
* Implementing safeguards for users who search on your platforms for weight loss products and GLP-1s, such as redirecting users to authoritative safety and educational resources when they search for weight loss products or GLP-1s;
* Ensuring that recommendation algorithms used to serve content and advertisements on your platforms do not trap users in filter bubbles of weight loss promotions.
William Tong, Connecticut Attorney General
Jeff Jackson, North Carolina Attorney General
Dave Yost, Ohio Attorney General
Dave Sunday, Pennsylvania Attorney General
Gwen Tauiliili-Langkilde, American Samoa Attorney General
Kris Mayes, Arizona Attorney General
Tim Griffin, Arkansas Attorney General
Rob Bonta, California Attorney General
Kathleen Jennings, Delaware Attorney General
Brian Schwalb, District of Columbia Attorney General
Anne E. Lopez, Hawaii Attorney General
Kwame Raoul, Illinois Attorney General
Brenna Bird, Iowa Attorney General
Kris Kobach, Kansas Attorney General
Liz Murrill, Louisiana Attorney General
Aaron M. Frey, Maine Attorney General
Anthony G. Brown, Maryland Attorney General
Andrea Joy Campbell, Massachusetts Attorney General
Dana Nessel, Michigan Attorney General
Keith Ellison, Minnesota Attorney General
Lynn Fitch, Mississippi Attorney General
Aaron D. Ford, Nevada Attorney General
John M. Formella, New Hampshire Attorney General
Matthew J. Platkin, New Jersey Attorney General
Raul Torrez, New Mexico Attorney General
Letitia James, New York Attorney General
Drew H. Wrigley, North Dakota Attorney General
Gentner Drummond, Oklahoma Attorney General
Dan Rayfield, Oregon Attorney General
Peter F. Neronha, Rhode Island Attorney General
Alan Wilson, South Carolina Attorney General
Marty Jackley, South Dakota Attorney General
Derek Brown, Utah Attorney General
Charity Clark, Vermont Attorney General
Nick Brown, Washington Attorney General
*
1 LegitScript, LegitScript's Data Reveals 1200% Increase in Violative and Problematic Advertisements for GLP-1 Medications (Oct. 2024), https://www.legitscript.com/about/press/glp-1-data-findings/.
2 These include Ageless Rx, Amble, Ark, Cello Health, DirectMeds, Dollar Dad Club, Effecty, Elevate, Fella Health, Freya, Fridays, Gala, Hims, HealthOn, Hers, Henry, Heyfeels, Ivim Health, Kin Meds, MD Exam, Measured Health, Mochi, NativeMed, Noom, NuForm Health, Piper, Queen Rx, Remmy, Rx Pros, Sana Direct, SapphireRX, Shed, Trim Rx, Weight Care, Willow, Zealthy, and Yucca Health.
3 Meta, About Meta's Prescription Drugs Advertising Policy, https://www.facebook.com/business/help/263390265553560?id=434838534925385.
4 Id.
5 Meta, About Meta's Health and Wellness Advertising Policy, https://www.facebook.com/business/help/2489235377779939?id=434838534925385.
6 Id.
7 J. Rad and G.J. Melendez-Torres, Critical Discourse Analysis of Social Media Advertisements for GLP-1 Receptor Agonist Weight Loss Drugs: Implications for Public Perceptions and Health Communication, BMC Public Health (Sept. 1, 2025), https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-025-24197-8.
8 https://www.facebook.com/ads/library/?id=4000186760292582; https://www.facebook.com/ads/library/?id=851188793704003; see Appendix 1.
9 https://instagram.com/p/DQXKpDpgHfD/; https://instagram.com/p/DQppIyyAHma/; see Appendix 2.
10 https://instagram.com/p/DQUbGyIDbKx/; see Appendix 2.
11 See Nikhil Sood and Rohini Garg, Global Rise of Compounded Weight Loss Medicines: A Worrisome Trend, J. Endocrine Society (June 7, 2025), https://academic.oup.com/jes/article/9/8/bvaf084/8158112.
12 Meta, Frauds, Scams, and Deceptive Practices https://transparency.meta.com/policies/communitystandards/fraud-and-scams/.
13 https://www.facebook.com/ads/library/?id=1523320795538989
14 https://www.facebook.com/ads/library/?id=1293446186133598
15 https://instagram.com/p/DQU0eWYDEkk/
16 See Appendix 3.
17 https://www.instagram.com/p/DLBYVsBAApR/, see Appendix 3.
18 See, e.g., https://www.facebook.com/ads/library/?id=847658211179014 (elderly patient); https://www.facebook.com/ads/library/?id=801307826004119 (group of nurses); https://www.facebook.com/ads/library/?id=730809849286915 (pharmacist); https://www.facebook.com/ads/library/?id=1872908603600820 (nurses at nurse station); https://www.facebook.com/ads/library/?id=843982294888184 (CVS pharmacist); https://www.facebook.com/ads/library/?id=1595511314940567 (police officer); see Appendix 3.
19 Mike Isaac and Eli Tan, OpenAI's New Video App Is Jaw-Dropping (for Better and Worse), The New York Times (Oct. 2, 2025), https://www.nytimes.com/2025/10/02/technology/openai-sora-video-app.html.
20 https://www.facebook.com/ads/library/?id=2500158893689706; see Appendix 3.
21 Nick Clegg, Labeling AI-Generated Images on Facebook, Instagram, and Threads, Feb. 6, 2024, https://about.fb.com/news/2024/02/labeling-ai-generated-images-on-facebook-instagram-and-threads/; Meta, Misinformation, https://transparency.meta.com/policies/community-standards/misinformation/ (accessed Nov. 6, 2025).
22 See generally 21 U.S.C. Sec. 353b.
23 See Food and Drug Administration, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (Apr. 28, 2025), available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policiescompounders-national-glp-1-supply-begins-stabilize.
24 See generally 21 U.S.C. Sec. 353a.
25 Food and Drug Administration, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (Sept. 25, 2025), https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concernsunapproved-glp-1-drugs-used-weight-loss ["FDA Concerns"]; Federal Bureau of Investigation, Safety Concerns Related to Fraudulent Compounding Practices Associated with Weight Loss Drugs (Feb. 28, 2025), https://www.ic3.gov/PSA/2025/PSA250228; Joshua J. Neumiller et al., Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association, 48 Diabetes Care 177-78 (2025), available at https://diabetesjournals.org/care/article/48/2/177/157478/Compounded-GLP-1-and-Dual-GIP-GLP-1-Receptor ["ADA Guidance"].
26 FDA Concerns, supra note 25.
27 Marta E. Wosinska, The Wild East of Semaglutide, Brookings (Apr. 21, 2025), https://www.brookings.edu/articles/the-wild-east-of-semaglutide/; Sood and Garg, supra note 11; ADA Guidance, supra note 25, at 178; Morten Hach et al., Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs, 41 Pharmaceutical Research 1991 (2024).
28 Peter J. Pitts, FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding Puts Patients at Risk 7 (Center for Medicine in the Public Interest July 21, 2025), https://mr.cdn.ignitecdn.com/client_assets/cmpiorg/media/attachments/687e/a93b/8bf7/5526/a476/a1e5/687ea93b8b f75526a476a1e5.pdf?1753131323; see also Shiv Sudhakar, Ozempic 'Microdosing' is the New Weight-Loss Trend: Should You Try It?, Fox News (Jan. 5, 2025), https://www.foxnews.com/health/ozempic-microdosing-new-weightloss-trend-should-you-try-it?
29 Matthew Perrone, FDA Takes Aim at Telehealth Companies for Promoting Unofficial Weight Loss Drug Dupes, PBS (Sept. 17, 2025), https://www.pbs.org/newshour/health/fda-takes-aim-at-telehealth-companies-for-promotingunofficial-weight-loss-drug-dupes.
30 See 16 C.F.R. Sec. 255.5 ("Disclosure of material connections"); Federal Trade Commission, Disclosures 101 for Social Media Influencers (Nov. 2019), https://www.ftc.gov/system/files/documents/plain-language/1001ainfluencer-guide-508_1.pdf; Meta, Branded Content Policies (last accessed Nov. 6, 2025), https://www.facebook.com/business/help/221149188908254; Alex Kresovich et al., Research Letter: HighEngagement Social Media Posts Related to Prescription Drug Promotion for 3 Major Drug Classes, JAMA Online (Nov. 13, 2025), https://jamanetwork.com/journals/jama/article-abstract/2841349. 31 National Consumers League, The Influence of Disinformation on Attitudes and Beliefs About Compounded GLP-1 Drugs: A Dose of Reality (May 2025), https://nclnet.org/wp-content/uploads/2025/05/The-Influence-ofDisinformation-on-Attitudes-and-Beliefs-About-Compounded-GLP-1-Drugs-Survey-Results.pdf.
* * *
Original text here: https://www.doj.nh.gov/news-and-media/attorney-general-formella-pushes-meta-take-action-misleading-ai-weight-loss-ads
Attorney General James Secures Conviction of Nursing Home Worker for Stealing Over $60,000 from Resident
ALBANY, New York, Dec. 18 -- New York Attorney General Letitia James issued the following news release:
* * *
Attorney General James Secures Conviction of Nursing Home Worker for Stealing Over $60,000 from Resident
*
New York Attorney General Letitia James today secured the guilty plea of Rachel Paillet, a nursing home aide formerly employed at The Pearl Nursing Center of Rochester (The Pearl), for stealing a resident's debit card and withdrawing over $60,000. An investigation by the Office of the Attorney General's (OAG) Medicaid Fraud Control Unit (MFCU) found that from April 2023 to November
... Show Full Article
ALBANY, New York, Dec. 18 -- New York Attorney General Letitia James issued the following news release:
* * *
Attorney General James Secures Conviction of Nursing Home Worker for Stealing Over $60,000 from Resident
*
New York Attorney General Letitia James today secured the guilty plea of Rachel Paillet, a nursing home aide formerly employed at The Pearl Nursing Center of Rochester (The Pearl), for stealing a resident's debit card and withdrawing over $60,000. An investigation by the Office of the Attorney General's (OAG) Medicaid Fraud Control Unit (MFCU) found that from April 2023 to November2023, Paillet made 220 withdrawals using the resident's card. Paillet spent the money on groceries, bills, and lottery tickets in an attempt to win back the money she had stolen. Paillet pleaded guilty today to Grand Larceny in the Third Degree in Monroe County Court.
"Nursing home residents must be able to trust and depend on their caregivers to treat them with dignity," said Attorney General James. "Rachel Paillet violated her duty to the residents she was supposed to care for and exploited a vulnerable New Yorker to line her own pockets. I will not tolerate any abuse or exploitation of nursing home residents and will use every resource at my disposal to make sure New Yorkers in nursing homes get the quality care they deserve."
Paillet's victim had a debit card that was primarily used for incidental costs and to cover monthly payments for his nursing home care. In November 2023, when his payment to The Pearl was declined for insufficient funds, the facility contacted his bank and learned of multiple ATM withdrawals between April and November of 2023. A MFCU investigation found that Paillet had stolen the resident's debit card and used it to withdraw cash at ATMs in the Rochester area, primarily at Delta Sonic Car Wash, Wegmans, and Tops locations. Paillet withdrew over $60,000 of the resident's money in the seven-month period.
Paillet pleaded guilty today to Grand Larceny in the Third Degree in Monroe County Court. She faces a sentence of 30 to 60 days in jail concurrent with five years of probation and an order to pay restitution.
Attorney General James is a leader in protecting nursing home residents and holding accountable the nursing homes that fail to properly care for New York seniors. In August 2025, Attorney General James secured $12 million and major reforms to stop resident neglect and financial fraud from the Van Duyn nursing home in Syracuse. In November 2024, Attorney General James secured a $45 million settlement and independent healthcare and financial monitors at four nursing homes owned and operated by Centers for Care throughout the state. In March 2024, Attorney General James secured $8.6 million and significant reforms to the Fulton Commons nursing home on Long Island. In April 2023, Attorney General James co-led a coalition of attorneys general in calling for increased transparency of nursing home ownership. In February and December 2023, Attorney General James and United States Attorney for the Northern District of New York Carla Freedman secured more than $7.1 million from the Saratoga Center for Rehabilitation and Skilled Nursing Care. In December 2022, Attorney General James sued Cold Spring Hills Center for Nursing and Rehabilitation on Long Island for diverting millions of dollars in funding from resident care, causing widespread resident neglect and abuse. In March 2024, a judge issued a decision holding Cold Spring Hills and its managing members liable for repeated illegality, and granted OAG's request for an independent healthcare monitor to oversee the facility.
Attorney General James encourages anyone with information or concerns about alarming nursing home conditions, or resident abuse or neglect, to file a confidential complaint online or call MFCU at (212) 417-5397. If the situation is an emergency, they should call 911.
MFCU Detective Stephen Sachman and Supervising Detective Stacey DiSanto investigated the matter under the supervision of Deputy Chief, Commanding Officer Ronald Lynch, with Auditor-Investigator Kaitlynn Arias, under the supervision of Regional Chief Auditor Jamie Powers and Chief Auditor Dejan Budimir.
The case is being prosecuted by MFCU's Special Assistant Attorney General Elizabeth Buckley and Rochester Regional Director William T. Gargan, with the assistance of MFCU Chief of Criminal Investigations Thomas O'Hanlon. MFCU is led by Deputy Attorney General Amy Held and Assistant Deputy Attorney General Paul J. Mahoney. MFCU is part of the Division of Criminal Justice, which is led by Chief Deputy Attorney General Jose Maldonado and overseen by First Deputy Attorney General Jennifer Levy.
New York MFCU's total funding for federal fiscal year (FY) 2026 is $70,793,651. Of that total, 75 percent, or $53,095,240, is awarded under a grant from the U.S. Department of Health and Human Services. The remaining 25 percent, totaling $17,698,411 for FY 2026, is funded by New York State.
***
Original text here: https://ag.ny.gov/press-release/2025/attorney-general-james-secures-conviction-nursing-home-worker-stealing-over
Attorney General Hilgers, Attorney General Rokita, and Six Other State Attorneys General Statement Regarding Executive Order Directing Rescheduling of Marijuana
LINCOLN, Nebraska, Dec. 18 -- Nebraska Attorney General Mike Hilgers issued the following news release:
* * *
Attorney General Hilgers, Attorney General Rokita, and Six Other State Attorneys General Statement Regarding Executive Order Directing Rescheduling of Marijuana
*
Since before President Trump took office, many of usthe Attorneys General of Nebraska, Indiana, Iowa, Idaho, Kansas, Louisiana, Oklahoma, and Wyominghave argued against the rescheduling of marijuana as a Schedule I drug. See July 2024 Comment of Nebraska and 10 Other States.
We all believe the science surrounding marijuanawhich
... Show Full Article
LINCOLN, Nebraska, Dec. 18 -- Nebraska Attorney General Mike Hilgers issued the following news release:
* * *
Attorney General Hilgers, Attorney General Rokita, and Six Other State Attorneys General Statement Regarding Executive Order Directing Rescheduling of Marijuana
*
Since before President Trump took office, many of usthe Attorneys General of Nebraska, Indiana, Iowa, Idaho, Kansas, Louisiana, Oklahoma, and Wyominghave argued against the rescheduling of marijuana as a Schedule I drug. See July 2024 Comment of Nebraska and 10 Other States.
We all believe the science surrounding marijuanawhichhas become only more clear in recent weeksproperly establishes it as a Schedule I drug, and we have seen firsthand the harm the drug has caused in our communities.
The negative impacts of expanded marijuana use, especially on children and adolescents, are worrisome. And the public policy challenges, such as the exponential increase in difficult-to-combat driving under the influence, are both significant and serious. We have conveyed our concerns to the Administration, and we are grateful for the Administration's good faith consideration of our views.
Because of our long-held views, we are concerned with the issuance of this Executive Order, which directs the U.S. Attorney General to "take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III." We will evaluate the order closely to determine how we can best continue to engage, protect the public health, and ensure the safety of our citizens.
***
Original text here: https://ago.nebraska.gov/news/attorney-general-hilgers-attorney-general-rokita-and-six-other-state-attorneys-general
AG's Office Secures Indictments Against Two Norfolk County Residents for Elder Neglect, Larceny, and Medicaid Fraud
BOSTON, Massachusetts, Dec. 18 -- Massachusetts Attorney General Andrea Joy Campbell issued the following news release:
* * *
AG's Office Secures Indictments Against Two Norfolk County Residents for Elder Neglect, Larceny, and Medicaid Fraud
*
The Massachusetts Attorney General's Office (AGO) today announced that Anne Marie Philippe, 48, and Sage Philippe, 55, both of Milton were indicted by a Norfolk County Grand Jury on various charges, including caretaker neglect of an elder, larceny, and Medicaid fraud. The AGO alleges that the married couple was responsible for the wellbeing of Sage's
... Show Full Article
BOSTON, Massachusetts, Dec. 18 -- Massachusetts Attorney General Andrea Joy Campbell issued the following news release:
* * *
AG's Office Secures Indictments Against Two Norfolk County Residents for Elder Neglect, Larceny, and Medicaid Fraud
*
The Massachusetts Attorney General's Office (AGO) today announced that Anne Marie Philippe, 48, and Sage Philippe, 55, both of Milton were indicted by a Norfolk County Grand Jury on various charges, including caretaker neglect of an elder, larceny, and Medicaid fraud. The AGO alleges that the married couple was responsible for the wellbeing of Sage'smother, Marie Philippe, but failed to properly care for her, resulting in serious bodily injury to her, all while billing MassHealth for services not provided to her.
According to the AGO, prior to her death, Marie was under the care of her son, Sage, who served as Marie's personal care attendant (PCA) program surrogate; her daughter-in-law, Anne Marie; and Anne Marie's mother, Gislaine Sainvil, who was serving as Marie's PCA. On April 15, 2024, Sage called 911 requesting that an ambulance take his mother to the hospital because a visiting nurse, who had been referred to Marie for treatment of pressure wounds, advised the family that Marie was experiencing worsening conditions. At the hospital, Marie was observed to have severe malnutrition and14 pressure ulcers on her body, including some as large as four by six inches. Marie died in the hospital two days later.
Through its investigation, and in coordination with the Norfolk District Attorney's Office, the AGO also alleges that Sage and Anne Marie routinely prevented visiting nurses from entering their home to check on Marie, and on the rare occasion that nurses were allowed inside, they were not allowed to touch Marie and were only allowed to perform a cursory exam in which Marie was mostly covered.
Furthermore, the AGO alleges that, from October 2023 through the time of Marie's death, Sage signed off on falsified timesheets certifying PCA services that Gislaine herself admitted were never provided to Marie. The AGO estimates that, in total, MassHealth was fraudulently billed for more than $96,000 in falsified claims for services never provided to Marie between October 2023 to May 2025.
MassHealth's PCA program helps individuals with chronic or long-term disabilities live independently in their community by providing medically necessary physical assistance with personal care needs. Through the PCA program, eligible MassHealth members employ PCAs to assist them with their activities of daily living. These services are paid for by MassHealth through a fiscal intermediary. Community based HHA and AFC programs also provide home health services to MassHealth members.
Sage and Anne Marie are scheduled to be arraigned at a later date. All of these charges are allegations, and the defendants are presumed innocent until proven guilty.
This matter is representative of the AGO's commitment to safeguarding residents from abuse and neglect, particularly within the PCA program. In September 2025, the AGO secured a guilty plea and state prison sentence of up to three years from a defendant in Worcester who orchestrated a widespread MassHealth fraud scheme involving the stealing of personal information from disabled, elderly, and unhoused individuals to bill for false PCA and home health services. In November 2024, the AGO announced indictments against three individuals accused of involuntary manslaughter, fraud, and neglect in connection to the inadequate care of an elderly victim, ultimately leading to her death.
This case was handled by Managing Attorney Heidi Lyn Gosule, AGO Fellow Sindhu Kadhiresan, Special Assistant Attorney General Sean Riley, Investigations Supervisor Dean Bates, Investigator Salvador Jaramillo, and Nurse Investigator Barbara Edwards, all of the AGO's Medicaid Fraud Division, with substantial assistance from the Norfolk County District Attorney's Office, the U.S. Department of Health and Human Services, Office of the Inspector General, South Shore Elder Services, and Randolph Police Department.
The AGO's Medicaid Fraud Division is a Medicaid Fraud Control Unit, annually certified by the U.S. Department of Health and Human Services to investigate and prosecute health care providers who defraud the state's Medicaid program, MassHealth. The Medicaid Fraud Division also has jurisdiction to investigate and prosecute complaints of abuse, neglect and financial exploitation of residents in long-term care facilities and of Medicaid patients in any health care setting. Individuals may file a MassHealth fraud complaint or report cases of abuse or neglect of Medicaid patients or long-term care residents by visiting the AGO's website.
The Massachusetts Medicaid Fraud Division receives 75 percent of its funding from the U.S. Department of Health and Human Services under a grant award totaling $6,458,176 for federal fiscal year 2026. The remaining 25 percent, totaling $2,152,724 for FY 2026, is funded by the Commonwealth of Massachusetts.
* Office of the Attorney General
The Attorney General is the chief lawyer and law enforcement officer of the Commonwealth of Massachusetts.
***
Original text here: https://www.mass.gov/news/ags-office-secures-indictments-against-two-norfolk-county-residents-for-elder-neglect-larceny-and-medicaid-fraud
AG Nessel on the MPSC Approving DTE's Application to Service Saline Data Center
LANSING, Michigan, Dec. 18 -- Michigan Attorney General Dana Nessel issued the following news release:
* * *
AG Nessel on the MPSC Approving DTE's Application to Service Saline Data Center
*
Michigan Attorney General Dana Nessel issued the following statement after the Michigan Public Service Commission (MPSC) approved DTE's ex parte application for approval of two special contracts to service a 1.4-gigawatt data center in Saline Township :
"After receiving more than 5,500 public comments, overwhelming opposition from community leaders, and bipartisan calls from public officials urging the
... Show Full Article
LANSING, Michigan, Dec. 18 -- Michigan Attorney General Dana Nessel issued the following news release:
* * *
AG Nessel on the MPSC Approving DTE's Application to Service Saline Data Center
*
Michigan Attorney General Dana Nessel issued the following statement after the Michigan Public Service Commission (MPSC) approved DTE's ex parte application for approval of two special contracts to service a 1.4-gigawatt data center in Saline Township :
"After receiving more than 5,500 public comments, overwhelming opposition from community leaders, and bipartisan calls from public officials urging theCommission to slow down, I am extremely disappointed in the MPSC's decision to fast-track DTE's secret application to service this massive data center without holding a contested case hearing. While I am relieved that the Commission at least purports to have placed some conditions on DTE's application, without being able to see the full, unredacted contract, and study the predicate conditions and enforcement mechanisms set by the Commission, it is impossible to verify any of these claims today. As Michigan's chief consumer advocate, my office is reviewing the Commission's order and considering what next steps we may be able to take to protect our residents.
"This secret contract still leaves Michiganders scrounging for hidden and vital details that could harm ratepayers should these AI corporations leave, move out of state, or simply go bankrupt. None of the conditions proposed by the Commission will bring these terms into public view, including what exit fee provisions might be in effect before December 2027.
"Rushing approval through an ex parte process lets DTE brush past important questions and shields the utility from the transparency the public deserves, and review by essential consumer protection organizations and offices such as mine, which I take personally as an elected official charged with protecting the consumers of this state.
"Our regulatory system only works if the process is done properly and transparently. When the utilities and MPSC cut corners, Michigan ratepayers are left unprotected. While this decision to forego a contested case is a major setback for consumer protection watchdogs, and a detriment to the public's trust in their appointed government regulators, my office will continue to stand with ratepayers, demand transparency from utilities, and push for a regulatory process that puts Michiganders, not corporations, first."
***
Original text here: https://www.michigan.gov/ag/news/press-releases/2025/12/18/ag-nessel-on-the-mpsc
